Ku S, Haque MA, Jang MJ, Ahn J, Choe D, Jeon JI, Park MS (2024) The role of Bifidobacterium in longevity and the future of probiotics
Mazdutide is based on oxyntomodulin, a natural hormone released from your intestines after eating
Experts hope the drug will be useful for both obesity and liver disease
They are not intended to represent clinical evidence in humans, and Retatrutide GLP-3 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Comparative health policy research could inform optimal coverage and implementation strategies
GLP1 receptor agonists, best known for treating type 2 diabetes and obesity, are showing promise for women with polycystic ovary syndrome (PCOS)